UNSPSC 51452203: Ftalofyne or phthalofyne

This classification denotes an antihelminthic agent with the molecular formula C14H14O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TA9XO4D05J, chemically known as 1,2-benzenedicarboxylic acid, mono (1-ethyl-1-methyl-2-propynyl) ester, sodium salt but generally known as ftalofyne, which bears US NIH Compound Identifier 8573. European Medicines Agency schedules Ftalofyne in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07819MIG.

UNSPSC 51452203 Ftalofyne or phthalofyne is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The two recent opportunities posted under this code are plainly unrelated to ftalofyne or phthalofyne chemistry: the Illinois Department of Public Health's award to Chartwell Rx LLC on August 28, 2026 for pharmaceutical warehouse supply of Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, and Seminole County, Florida's IFB on June 30, 2026 for Naloxone and drug deactivation systems. Neither solicitation involves the specialty chemical named in the code itself.

The mismatch between the code taxonomy and the recent opportunities posted under it suggests either a vendor or procurement system classification error. The code does not show relevant recent activity for business development purposes. No issuing body has posted an open solicitation or award matching the ftalofyne commodity in the recent record.